Keyphrases
Neoantigen
100%
Glioblastoma
100%
Newly Diagnosed Glioblastoma
100%
Molecular Characterization
100%
Multi-sector
100%
Peptide Vaccine Design
100%
Personalized Peptide Vaccine
100%
Clinical Trials
60%
Cancer Vaccine
40%
T Cells
40%
Immune Response
20%
Chemotherapy
20%
Peripheral Blood Mononuclear Cells
20%
In Cancer
20%
Clonality
20%
Clinical Applicability
20%
Immunogenicity
20%
Genomic Landscape
20%
Tumor Biopsy
20%
Tumor Site
20%
Combined Modality Therapy
20%
Vaccine Design
20%
Neoantigen Vaccine
20%
Effector T Cells
20%
Tumor Immunogenicity
20%
ELISpot Assay
20%
Immunology and Microbiology
Neoantigen
100%
Peptide Vaccine
100%
T Cell
50%
Cancer Vaccine
33%
Vaccine Efficacy
16%
Immunotherapy
16%
Peripheral Blood Mononuclear Cell
16%
Enzyme-Linked Immunospot Assay
16%
Immunoreactivity
16%
Immunogenicity
16%
Clonal Variation
16%
Tumor Immunogenicity
16%